首页 > 最新文献

Ayu最新文献

英文 中文
Central nervous system depressant activity of Jatamansi (Nardostachys jatamansi DC.) rhizome. 野檀根茎对中枢神经系统的抑制作用。
Ayu
Pub Date : 2020-10-01 Epub Date: 2022-06-03 DOI: 10.4103/ayu.AYU_251_20
Kalpesh Panara, Mukeshkumar Nariya, Nishteswar Karra

Background: Sleep disorders have a comparatively high prevalence worldwide and create a burden on the health system. Pharmacological agents used for insomnia are associated with considerable side effects. Therefore, searching for safe and effective agents from plant-based natural sources is a worthy effort. Jatamansi (Nardostachys jatamansi DC.) rhizome has been recommended for insomnia and mental conditions in the Indian system of medicine.

Aim: This study aimed to determine central nervous system (CNS) depressant activity of Jatamansi (N. jatamansi) rhizome on experimental animals.

Materials and methods: Gross behavior study and open field test (locomotor activity) were performed by using Charle's foster albino rats whereas rota-rod test and pentobarbital-induced sleep test in Swiss albino mice. Animals were divided into 3 groups (per model) having six animals in each group. The control group was treated with water, the standard group with diazepam and the test drug with powder of N. Jatamansi rhizome. Results were calculated by one-way ANOVA and post hoc test with P < 0.05 as significant.

Results: Data suggested that Jatamansi did not produce a significant effect on the behavior of animals. It reduced the horizontal activity significantly (P < 0.001) in the open field apparatus. The test drug did not show a significant decrease in latency of fall-off time in rota-rod performance in mice. Still, it exerted a significant effect by a reduction in latency of onset of sleep (P < 0.01) and also extended the total duration of sleep (P < 0.05) in albino mice in comparison to the control group.

Conclusion: This study shows that Jatamansi rhizome powder possesses CNS depressant activity without affecting gross behavior and muscle coordination in rats.

背景:睡眠障碍在世界范围内具有较高的患病率,并对卫生系统造成负担。用于治疗失眠的药物有相当大的副作用。因此,从植物性天然资源中寻找安全有效的药物是一项值得努力的工作。在印度的医学体系中,野檀根茎被推荐用于治疗失眠和精神疾病。目的:研究野檀根茎对实验动物中枢神经系统的抑制作用。材料与方法:采用charles’s寄养的白化大鼠进行大体行为实验和开放场实验(运动活动),瑞士白化小鼠进行旋转棒实验和戊巴比妥诱导睡眠实验。将动物分为3组(每个模型),每组6只。对照组用水治疗,标准组用地西泮治疗,试验组用野檀香粉治疗。结果采用单因素方差分析和事后检验,以P < 0.05为显著性。结果:数据表明,Jatamansi对动物的行为没有显著影响。在野外试验中,显著降低了水平活性(P < 0.001)。试验药物对小鼠旋转杆性能的脱落潜伏期没有显著降低。然而,与对照组相比,它在减少白化小鼠的睡眠潜伏期(P < 0.01)和延长总睡眠时间(P < 0.05)方面发挥了显著作用。结论:藿香散具有抑制大鼠中枢神经系统的作用,但不影响大鼠的大体行为和肌肉协调能力。
{"title":"Central nervous system depressant activity of <i>Jatamansi</i> (<i>Nardostachys jatamansi</i> DC.) rhizome.","authors":"Kalpesh Panara,&nbsp;Mukeshkumar Nariya,&nbsp;Nishteswar Karra","doi":"10.4103/ayu.AYU_251_20","DOIUrl":"https://doi.org/10.4103/ayu.AYU_251_20","url":null,"abstract":"<p><strong>Background: </strong>Sleep disorders have a comparatively high prevalence worldwide and create a burden on the health system. Pharmacological agents used for insomnia are associated with considerable side effects. Therefore, searching for safe and effective agents from plant-based natural sources is a worthy effort. <i>Jatamansi</i> (<i>Nardostachys</i> <i>jatamansi</i> DC.) rhizome has been recommended for insomnia and mental conditions in the Indian system of medicine.</p><p><strong>Aim: </strong>This study aimed to determine central nervous system (CNS) depressant activity of <i>Jatamansi</i> (<i>N</i>. <i>jatamansi)</i> rhizome on experimental animals.</p><p><strong>Materials and methods: </strong>Gross behavior study and open field test (locomotor activity) were performed by using Charle's foster albino rats whereas rota-rod test and pentobarbital-induced sleep test in <i>Swiss albino</i> mice. Animals were divided into 3 groups (per model) having six animals in each group. The control group was treated with water, the standard group with diazepam and the test drug with powder of <i>N</i>. <i>Jatamansi</i> rhizome. Results were calculated by one-way ANOVA and <i>post hoc</i> test with <i>P</i> < 0.05 as significant.</p><p><strong>Results: </strong>Data suggested that <i>Jatamansi</i> did not produce a significant effect on the behavior of animals. It reduced the horizontal activity significantly (<i>P</i> < 0.001) in the open field apparatus. The test drug did not show a significant decrease in latency of fall-off time in rota-rod performance in mice. Still, it exerted a significant effect by a reduction in latency of onset of sleep (<i>P</i> < 0.01) and also extended the total duration of sleep (<i>P</i> < 0.05) in albino mice in comparison to the control group.</p><p><strong>Conclusion: </strong>This study shows that <i>Jatamansi</i> rhizome powder possesses CNS depressant activity without affecting gross behavior and muscle coordination in rats.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f6/a6/AYU-41-250.PMC9261992.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40489987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Reformations- A need for Ayurveda education. 改革-阿育吠陀教育的需要。
Ayu
Pub Date : 2020-10-01 Epub Date: 2022-06-03 DOI: 10.4103/ayu.ayu_79_22
Mandip Goyal
The persistence and popularity of any medical science depend on the status of its upgradation. Continuous pooling of the information is required to keep any science alive and to make it applicable and suitable per the need of the society: the same is applicable to traditional systems of medicine. The Information available in the texts of traditional medicines, though is widely used by the physicians and experts, however there is extreme need to rethink and reform the information education and practices of traditional systems of in a way, it can be easily accepted in the present era. The first step to achieving this goal is the reforming of the education system. The education pattern of the traditional system should be in a format where students are taught and trained in a manner that they inculcate in themselves the thought process of thinking in a that helps to understand the ancient science in the parlance ofmodern advancements. The students trained in this way may become the torchbearer of traditional medicine where they are capable to apply the medical science appropriately. This will also build in them a real sense of confidence and trust in their own system.
{"title":"Reformations- A need for Ayurveda education.","authors":"Mandip Goyal","doi":"10.4103/ayu.ayu_79_22","DOIUrl":"https://doi.org/10.4103/ayu.ayu_79_22","url":null,"abstract":"The persistence and popularity of any medical science depend on the status of its upgradation. Continuous pooling of the information is required to keep any science alive and to make it applicable and suitable per the need of the society: the same is applicable to traditional systems of medicine. The Information available in the texts of traditional medicines, though is widely used by the physicians and experts, however there is extreme need to rethink and reform the information education and practices of traditional systems of in a way, it can be easily accepted in the present era. The first step to achieving this goal is the reforming of the education system. The education pattern of the traditional system should be in a format where students are taught and trained in a manner that they inculcate in themselves the thought process of thinking in a that helps to understand the ancient science in the parlance ofmodern advancements. The students trained in this way may become the torchbearer of traditional medicine where they are capable to apply the medical science appropriately. This will also build in them a real sense of confidence and trust in their own system.","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/52/86/AYU-41-209.PMC9261996.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40490427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Guggulu and Shallaki based Ksharasutra with Triphala Guggulu orally in the management of Bhagandara w.s.r. to fistula-in-ano: A open labelled randomized comparative clinical study. Guggulu和Shallaki为基础的Ksharasutra联合Triphala Guggulu口服治疗Bhagandara w.s.r.瘘管的疗效:一项开放标记随机对照临床研究。
Ayu
Pub Date : 2020-10-01 Epub Date: 2022-06-03 DOI: 10.4103/ayu.AYU_156_16
Aditya Nema, Sanjay Kumar Gupta, Tukaram Dudhamal, Vyasdeva Mahanta

Background: Bhagandara is a disease of ano-rectal region and can be correlated with fistula-in-ano. Ksharasutra (application of medicated thread) is being practiced for ano-rectal disorders, particularly in Bhagandara. Guggulu-based Ksharasutra has shown good results in previous studies. Literatures and experiments of Shallaki showed anti-inflammatory, antifungal, analgesic, wound healing properties and Shallaki Niryasa (resin of Boswellia serrate Roxb.) is also having binding effect. Here, Shallaki-based Ksharasutra is used in comparison of Guggulu-based Ksharasutra with Triphala Guggulu orally for better outcome in the management of Bhagandara.

Aim: The aim of this study was to evaluate and compare the efficacy of Guggulu and Shallaki based Ksharasutra with Triphala Guggulu orally in the management of Bhagandara.

Materials and methods: Total 46 patients were registered and randomly allocated by computer generated chart by into three groups. In group A (n = 15), Guggulu-based Ksharasutra was applied in fistula-in-ano without any oral medication; in group B (n = 16), Guggulu-based Ksharasutra was applied with Triphala Guggulu orally; and in group C (n = 15), Shallaki-based Ksharasutra was applied with Triphala Guggulu orally. Patients were assessed for pain, discharge, itching and swelling in the affected region and unit cutting time (UCT) of fistulous tract. Ksharasutra was changed by railroad technique on weekly based follow-up till complete healing of the tract occurred.

Results: In group A, relief in pain, discharge, and swelling was found and was statistically highly significant while insignificant result was found in itching after cut through of the fistulous tract and the same results were found in group B (n = 14) and group C (n = 15). The mean UCT was higher in group A (8.94 days/cm) than in group C (8.43 days/cm) and in group B (8.59 days/cm).

Conclusion: Shallaki based Ksharasutra is more effective in cutting of fistula track while Guggulu based Ksharasutra is more effective in pain relief in the treatment of Bhagandara, along with oral Triphala Guggulu as compared to Guggulu based Ksharasutra with and without Triphala Guggulu orally.

背景:Bhagandara是一种肛肠区疾病,可与肛瘘相关。Ksharasutra(应用药物线)正在用于肛肠疾病,特别是在巴甘达拉。以古古鲁为基础的Ksharasutra在之前的研究中显示出良好的结果。文献和实验表明,夏拉木具有抗炎、抗真菌、镇痛、伤口愈合等作用,夏拉木树脂也具有结合作用。在这里,Shallaki-based Ksharasutra被用来比较guguulu -based Ksharasutra和Triphala guguulu口服药,以获得更好的治疗效果。目的:本研究的目的是评价和比较古古鲁和夏拉基口服法与Triphala古古鲁口服法治疗大腹大肠炎的疗效。材料与方法:纳入46例患者,采用计算机生成图表法随机分为3组。A组(n = 15)采用guggulu - Ksharasutra治疗瘘管,不使用任何口服药物;B组(n = 16)采用gugugulu为基础的Ksharasutra联合Triphala gugugulu口服;C组(n = 15)应用夏拉基法经加口服三七。评估患者患区疼痛、分泌物、瘙痒、肿胀及瘘道单位切割时间(UCT)。在每周一次的随访中,采用铁路技术改变经络,直至尿道完全愈合。结果:A组患者疼痛、分泌物、肿胀均有明显缓解,且差异有统计学意义,而瘘道切开后瘙痒无统计学意义,B组(n = 14)、C组(n = 15)差异无统计学意义。A组平均UCT (8.94 d /cm)高于C组(8.43 d /cm)和B组(8.59 d /cm)。结论:以Shallaki为基础的经切瘘道更有效,而以guguulu为基础的经切瘘道更有效,与口服Triphala gugugululu相比,以guguulu为基础的经切瘘术与口服Triphala gugugululu相比,在治疗Bhagandara时口服Triphala gugugululu更有效。
{"title":"Efficacy of <i>Guggulu</i> and <i>Shallaki</i> based <i>Ksharasutra</i> with <i>Triphala Guggulu</i> orally in the management of <i>Bhagandara</i> w.s.r. to fistula-in-ano: A open labelled randomized comparative clinical study.","authors":"Aditya Nema,&nbsp;Sanjay Kumar Gupta,&nbsp;Tukaram Dudhamal,&nbsp;Vyasdeva Mahanta","doi":"10.4103/ayu.AYU_156_16","DOIUrl":"https://doi.org/10.4103/ayu.AYU_156_16","url":null,"abstract":"<p><strong>Background: </strong><i>Bhagandara</i> is a disease of ano-rectal region and can be correlated with fistula-in-ano. <i>Ksharasutra</i> (application of medicated thread) is being practiced for ano-rectal disorders, particularly in <i>Bhagandara</i>. <i>Guggulu</i>-based <i>Ksharasutra</i> has shown good results in previous studies. Literatures and experiments of <i>Shallaki</i> showed anti-inflammatory, antifungal, analgesic, wound healing properties and <i>Shallaki</i> <i>Niryasa</i> (resin of <i>Boswellia serrate</i> Roxb.) is also having binding effect. Here, <i>Shallaki</i>-based <i>Ksharasutra</i> is used in comparison of <i>Guggulu</i>-based <i>Ksharasutra</i> with <i>Triphala</i> <i>Guggulu</i> orally for better outcome in the management of <i>Bhagandara</i>.</p><p><strong>Aim: </strong>The aim of this study was to evaluate and compare the efficacy of <i>Guggulu</i> and <i>Shallaki</i> based <i>Ksharasutra</i> with <i>Triphala</i> <i>Guggulu</i> orally in the management of <i>Bhagandara</i>.</p><p><strong>Materials and methods: </strong>Total 46 patients were registered and randomly allocated by computer generated chart by into three groups. In group A (<i>n</i> = 15), <i>Guggulu</i>-based <i>Ksharasutra</i> was applied in fistula-in-ano without any oral medication; in group B (<i>n</i> = 16), <i>Guggulu</i>-based <i>Ksharasutra</i> was applied with <i>Triphala</i> <i>Guggulu</i> orally; and in group C (<i>n</i> = 15), <i>Shallaki</i>-based <i>Ksharasutra</i> was applied with <i>Triphala</i> <i>Guggulu</i> orally. Patients were assessed for pain, discharge, itching and swelling in the affected region and unit cutting time (UCT) of fistulous tract. <i>Ksharasutra</i> was changed by railroad technique on weekly based follow-up till complete healing of the tract occurred.</p><p><strong>Results: </strong>In group A, relief in pain, discharge, and swelling was found and was statistically highly significant while insignificant result was found in itching after cut through of the fistulous tract and the same results were found in group B (<i>n</i> = 14) and group C (<i>n</i> = 15). The mean UCT was higher in group A (8.94 days/cm) than in group C (8.43 days/cm) and in group B (8.59 days/cm).</p><p><strong>Conclusion: </strong><i>Shallaki</i> based <i>Ksharasutra</i> is more effective in cutting of fistula track while <i>Guggulu</i> based <i>Ksharasutra</i> is more effective in pain relief in the treatment of <i>Bhagandara</i>, along with oral <i>Triphala</i> <i>Guggulu</i> as compared to <i>Guggulu</i> based <i>Ksharasutra</i> with and without <i>Triphala</i> <i>Guggulu</i> orally.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3b/44/AYU-41-211.PMC9261991.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40489988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative pharmacognosy and phytochemical evaluation of leaf, root and stem of Psoralea corylifolia Linn. (Bakuchi). 补骨脂叶、根、茎的比较生药学及植物化学评价。(Bakuchi)。
Ayu
Pub Date : 2020-10-01 Epub Date: 2022-06-03 DOI: 10.4103/ayu.ayu_79_21
Sarika Makwana, Nikhil Mehere, Prashant Bedarkar, Patgiri Biswajyoti, C R Harisha

Background: Psoralea corylifolia Linn. (P. Corylifolia L.), frequently familiar as Bakuchi in Samskrit, is an endangered and medicinally important plant. Its medicinal usage is reported in Indian pharmaceutical codex, the Chinese, British and the American Pharmacopoeia, and in different traditional systems of medicines such as Ayurveda, Unani and Siddha. However, no scientifically pharmacognosy study has been reported on leaf, root, and stem part of P. Corylifolia L. Classics emphasized the use of leaf, root and stem of P. Corylifolia L. for on the management of dental carries, diarrhea, dysentery, etc., in the form of local application as well as internal administration.

Aim: The aim of this study was to evaluate comparative pharmacognosy, phytochemical studies, and physicochemical analysis of leaf, root and stem of P. Corylifolia L.

Materials and methods: Studies of leaf, root, stem, and their powder for phytochemical tests, histochemical tests, psoralen chemical test, and physicochemical analysis were performed by standard methods.

Result: All the different parts of the plant exhibit oleoresin and other cellular contents, i.e., vessels fibers, lignified pitted vessels, etc., in pharmacognosy studies. In phytochemical study; observations indicate that coumarins, steroids, and flavonoids are present in leaf, stem, and root samples. Basified alcoholic extracts of powders of all test samples showed yellowish color of fluorescence at 366 nm whereas none of the samples showed any color at 254 nm during chemical test of psoralen.

Conclusion: Pharmacognostical study on leaf, root and stem of Bakuchi (P. corylifolia L.) contributed Certain pharmacognostical parameters i.e; oleoresin, vascular bundles, parenchyma cells with rhomboidal crystals, pericyclic fibres etc parameters that will be applicable for authentication and identification of the parts of drug. There is a need to focus on the preliminary throughput phytochemical screening of plants for their probable use in therapeutics. As no published evidences are developed on comparative pharmacognosy and preliminary physicochemical analysis of leaf, root and stem of P. corylifolia L. plant, the results documented in the present study may be used as a standard in subsequent studies. These observations can be of use for further research studies.

背景:补骨脂。(P. Corylifolia L.),在Samskrit经常被称为Bakuchi,是一种濒危的重要药用植物。印度药典、中国、英国和美国药典以及不同的传统药物体系(如阿育吠陀、乌纳尼和悉达)都报道了它的药用价值。然而,目前还没有对雪兰叶、根、茎部分进行科学生药学研究的报道。经典文献强调雪兰叶、根、茎用于治疗牙病、腹泻、痢疾等,既可局部应用,也可内服。目的:对雪兰叶、根、茎的比较生药学、植物化学研究和理化分析进行评价。材料和方法:采用标准方法对雪兰叶、根、茎及其粉末进行植物化学试验、组织化学试验、补骨脂素化学试验和理化分析。结果:在生药学研究中,该植物的所有不同部位均表现出油树脂和其他细胞内容物,即血管纤维、木质素化的凹陷血管等。植物化学研究;观察表明香豆素、类固醇和类黄酮存在于叶、茎和根样品中。在补骨脂素化学测试中,所有样品粉末的碱化酒精提取物在366 nm处显示淡黄色荧光,而在254 nm处没有样品显示任何颜色。结论:竹叶、根、茎的生药学研究提供了一定的生药学参数;油树脂、维管束、含菱形晶体的薄壁细胞、周环纤维等参数,适用于药品成分的鉴别和鉴定。有必要把重点放在植物的初步通量植物化学筛选上,以便它们可能用于治疗。由于在比较生药学和叶、根、茎的初步理化分析方面尚无文献发表,本研究结果可作为后续研究的参考依据。这些观察结果可用于进一步的研究。
{"title":"Comparative pharmacognosy and phytochemical evaluation of leaf, root and stem of <i>Psoralea corylifolia</i> Linn. (<i>Bakuchi</i>).","authors":"Sarika Makwana,&nbsp;Nikhil Mehere,&nbsp;Prashant Bedarkar,&nbsp;Patgiri Biswajyoti,&nbsp;C R Harisha","doi":"10.4103/ayu.ayu_79_21","DOIUrl":"https://doi.org/10.4103/ayu.ayu_79_21","url":null,"abstract":"<p><strong>Background: </strong><i>Psoralea</i> <i>corylifolia</i> Linn. (<i>P</i>. <i>Corylifolia</i> L.), frequently familiar as <i>Bakuchi</i> in Samskrit, is an endangered and medicinally important plant. Its medicinal usage is reported in Indian pharmaceutical codex, the Chinese, British and the American Pharmacopoeia, and in different traditional systems of medicines such as Ayurveda, Unani and Siddha. However, no scientifically pharmacognosy study has been reported on leaf, root, and stem part of <i>P</i>. <i>Corylifolia</i> L. Classics emphasized the use of leaf, root and stem of <i>P</i>. <i>Corylifolia</i> L. for on the management of dental carries, diarrhea<b>,</b> dysentery, etc., in the form of local application as well as internal administration.</p><p><strong>Aim: </strong>The aim of this study was to evaluate comparative pharmacognosy, phytochemical studies, and physicochemical analysis of leaf, root and stem of <i>P</i>. <i>Corylifolia</i> L.</p><p><strong>Materials and methods: </strong>Studies of leaf, root, stem, and their powder for phytochemical tests, histochemical tests, psoralen chemical test, and physicochemical analysis were performed by standard methods.</p><p><strong>Result: </strong>All the different parts of the plant exhibit oleoresin and other cellular contents, i.e., vessels fibers, lignified pitted vessels, etc., in pharmacognosy studies. In phytochemical study; observations indicate that coumarins, steroids, and flavonoids are present in leaf, stem, and root samples. Basified alcoholic extracts of powders of all test samples showed yellowish color of fluorescence at 366 nm whereas none of the samples showed any color at 254 nm during chemical test of psoralen.</p><p><strong>Conclusion: </strong>Pharmacognostical study on leaf, root and stem of <i>Bakuchi</i> (<i>P. corylifolia</i> L.) contributed Certain pharmacognostical parameters i.e; oleoresin, vascular bundles, parenchyma cells with rhomboidal crystals, pericyclic fibres etc parameters that will be applicable for authentication and identification of the parts of drug. There is a need to focus on the preliminary throughput phytochemical screening of plants for their probable use in therapeutics. As no published evidences are developed on comparative pharmacognosy and preliminary physicochemical analysis of leaf, root and stem of <i>P. corylifolia</i> L. plant, the results documented in the present study may be used as a standard in subsequent studies. These observations can be of use for further research studies.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ce/23/AYU-41-235.PMC9261993.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40489991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Adaptogenic and immunomodulatory activity of Virgozest Avaleha - An ayurvedic proprietary formulation. 阿育吠陀的一种专有配方——荆芥的适应性和免疫调节活性。
Ayu
Pub Date : 2020-10-01 Epub Date: 2022-06-03 DOI: 10.4103/ayu.ayu_57_21
Devang Y Joshi, Nidhi Ranpariya, Mukeshkumar B Nariya

Introduction: Rasayana (rejuvenator) or adaptogenic drugs have been proved to produce the complete potential to prevent diseases and degenerative changes that leads to diseases and promote longevity by providing strength and immunity. Virgozest Avaleha is a poly-herbal formulation claimed to serve as adaptogenic, and immunomodulatory, as a health tonic, enriched with dry fruits, and ingredients containing natural supplements of Vitamin E and proteins.

Aim: To evaluate the adaptogenic activity and humoral immune activity of virgozest Avaleha in Wistar albino rats.

Materials and methods: Virgozest Avaleha was evaluated for adaptogenic activity against swimming stress-induced changes and hypothermia in albino rats. The humoral immune activity of virgozest Avaleha was evaluated against sheep red blood cells (SRBCs)-induced response in albino rats with the inclusion of cyclophosphamide as immune suppressant agent.

Results: In adaptogenic activity, virgozest Avaleha (450 and 900 mg/kg) exhibited an increase in physical activity, decrease in stress-induced hypothermia, and serum cortisol level when compared to the stress control group of albino rats. In humoral immune activity, virgozest Avaleha reversed the effects of cyclophosphamide-induced adverse changes on spleen and lymph node, and produced a significant increase in serum antibody titer in SRBCs-sensitized rats.

Conclusion: The present study concluded that virgozest Avaleha has adaptogenic and humoral immune activity in Wistar albino rats, which may suggest the Rasayana like properties of Ayurvedic formulation.

介绍:Rasayana(返老还老)或适应性药物已被证明具有预防疾病和导致疾病的退行性变化的完全潜力,并通过提供力量和免疫力来延长寿命。Virgozest Avaleha是一种多草药配方,据称具有适应性和免疫调节作用,是一种健康补品,富含干果,成分中含有天然维生素E和蛋白质补充剂。目的:评价茯苓多糖对Wistar白化大鼠的适应活性和体液免疫活性。材料与方法:对白化大鼠游泳应激性改变和低温的适应活性进行了评价。用环磷酰胺作为免疫抑制剂,对白化大鼠羊红细胞(srbc)诱导的免疫反应进行了免疫活性评价。结果:在适应活性方面,与应激对照组的白化大鼠相比,450和900 mg/kg的阿瓦雷哈(virgozest avalha)表现出体力活动增加,应激性低温降低,血清皮质醇水平降低。在体液免疫活性方面,枸杞可逆转环磷酰胺诱导的脾和淋巴结不良变化,显著提高srbc致敏大鼠的血清抗体滴度。结论:阿瓦莱哈对Wistar白化大鼠具有适应免疫和体液免疫活性,可能与阿育吠陀制剂的Rasayana相似。
{"title":"Adaptogenic and immunomodulatory activity of Virgozest <i>Avaleha</i> - An ayurvedic proprietary formulation.","authors":"Devang Y Joshi,&nbsp;Nidhi Ranpariya,&nbsp;Mukeshkumar B Nariya","doi":"10.4103/ayu.ayu_57_21","DOIUrl":"https://doi.org/10.4103/ayu.ayu_57_21","url":null,"abstract":"<p><strong>Introduction: </strong><i>Rasayana</i> (rejuvenator) or adaptogenic drugs have been proved to produce the complete potential to prevent diseases and degenerative changes that leads to diseases and promote longevity by providing strength and immunity. Virgozest <i>Avaleha</i> is a poly-herbal formulation claimed to serve as adaptogenic, and immunomodulatory, as a health tonic, enriched with dry fruits, and ingredients containing natural supplements of Vitamin E and proteins.</p><p><strong>Aim: </strong>To evaluate the adaptogenic activity and humoral immune activity of virgozest <i>Avaleha</i> in Wistar albino rats.</p><p><strong>Materials and methods: </strong>Virgozest <i>Avaleha</i> was evaluated for adaptogenic activity against swimming stress-induced changes and hypothermia in albino rats. The humoral immune activity of virgozest <i>Avaleha</i> was evaluated against sheep red blood cells (SRBCs)-induced response in albino rats with the inclusion of cyclophosphamide as immune suppressant agent.</p><p><strong>Results: </strong>In adaptogenic activity, virgozest <i>Avaleha</i> (450 and 900 mg/kg) exhibited an increase in physical activity, decrease in stress-induced hypothermia, and serum cortisol level when compared to the stress control group of albino rats. In humoral immune activity, virgozest <i>Avaleha</i> reversed the effects of cyclophosphamide-induced adverse changes on spleen and lymph node, and produced a significant increase in serum antibody titer in SRBCs-sensitized rats.</p><p><strong>Conclusion: </strong>The present study concluded that virgozest <i>Avaleha</i> has adaptogenic and humoral immune activity in Wistar albino rats, which may suggest the <i>Rasayana</i> like properties of Ayurvedic formulation.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/67/a9/AYU-41-255.PMC9261994.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40490431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of Guduchighana Vati in asymptomatic and mild-to-moderate cases of coronavirus disease-19: A randomized controlled pilot study Guduchighana Vati治疗无症状和轻中度冠状病毒病的疗效和安全性:一项随机对照试点研究
Ayu
Pub Date : 2020-07-01 DOI: 10.4103/ayu.ayu_11_21
A. Rai, U. Shukla, Nitin Ujjaliya, Pankaj Gupta, V. Khare, B. Yadav, Hetalben Amin, Rakesh Rana, Arunabh Tripathi, S. Khanduri, B. Sharma, B. Chandrasekhararao, Narayanam Srikanth, K. Dhiman
Background: Currently, there is no approved treatment for the management of coronavirus disease (COVID-19). Drug repurposing of existing medications could be a possible way to find out a novel therapeutic entity to combat the COVID-19. Aim: To determine the clinical efficacy and safety of an Ayurveda intervention (Guduchighana Vati) in asymptomatic and mild-to-moderate cases of COVID-19. Materials and methods: This was an open-label randomized controlled pilot study with a sample size of 30 participants (15 in each arm). The participants were asymptomatic or mild to moderate cases of COVID-19. Guduchighana Vati 500 mg twice daily for 10 days was administered in the study group and Hydroxychloroquine for 5 days in the control group. Paracetamol, Vitamin C, Multivitamin, and Zinc were also provided in the control group. The main outcome measures were to negative real-time reverse transcription–polymerase chain reaction (RT-PCR) assay for COVID-19, proportion of participants with negative RT-PCR for COVID-19 at 5th and 10th day, proportion of participants with clinical recovery, improvement in laboratory parameters, and incidence of adverse drug reaction/adverse event (ADR/AE). The results of RT-PCR and clinical recovery were compared between groups using Chi-square test. The data related to laboratory parameters were compared within group using paired sample t-test/Wilcoxon signed-rank test and between groups using independent sample t-test/Mann–Whitney test. Results: The proportion of participants with negative RT-PCR for COVID-19 in the Guduchighana Vati group (93.3%) was better as compared to the control group (66.6%) till 10th day of the study period. Though, the results are statistically not significant (P = 0.068). All the symptomatic patients in the Guduchighana Vati group clinically recovered whereas one patient remained symptomatic in the control group on the 5th day. No symptoms of COVID-19 were observed at 10th day in both the groups. No ADR/serious adverse event were observed during the study period in either of the groups. Conclusion: In this study on asymptomatic and mild to moderate cases of COVID-19, Guduchighana Vati showed numerically better proportion of participants with negative RT-PCR assay for COVID-19 and reduced time to clinical improvement which requires confirmation through studies with larger sample size. Although, the study outcomes are statistically not significant which may be due to small sample size.
背景:目前,还没有批准的治疗冠状病毒病(COVID-19)的药物。对现有药物进行药物再利用,有可能开发出对抗新冠病毒的新型治疗药物。目的:探讨阿育吠陀治疗新型冠状病毒肺炎(COVID-19)无症状和轻中度患者的临床疗效和安全性。材料和方法:这是一项开放标签随机对照先导研究,样本量为30名参与者(每组15名)。参与者为无症状或轻至中度COVID-19病例。研究组给予Guduchighana Vati 500 mg,每日2次,连用10天;对照组给予羟氯喹,连用5天。对照组同时给予扑热息痛、维生素C、多种维生素和锌。主要观察指标为实时逆转录聚合酶链反应(RT-PCR)检测COVID-19阴性、第5天和第10天RT-PCR检测COVID-19阴性比例、临床恢复比例、实验室参数改善比例、药物不良反应/不良事件发生率(ADR/AE)。采用卡方检验比较两组患者的RT-PCR结果和临床恢复情况。与实验室参数相关的数据,组内比较采用配对样本t检验/Wilcoxon符号秩检验,组间比较采用独立样本t检验/ Mann-Whitney检验。结果:到研究期第10天,Guduchighana Vati组RT-PCR阴性的参与者比例(93.3%)优于对照组(66.6%)。然而,结果没有统计学意义(P = 0.068)。Guduchighana Vati组有症状患者均临床恢复,对照组1例患者在第5天仍有症状。第10天,两组均未观察到COVID-19症状。两组在研究期间均未观察到不良反应/严重不良事件。结论:在无症状和轻中度COVID-19病例的研究中,Guduchighana Vati的RT-PCR阴性比例更高,临床改善时间更短,这需要通过更大样本量的研究来证实。然而,由于样本量小,研究结果在统计学上并不显著。
{"title":"Efficacy and safety of Guduchighana Vati in asymptomatic and mild-to-moderate cases of coronavirus disease-19: A randomized controlled pilot study","authors":"A. Rai, U. Shukla, Nitin Ujjaliya, Pankaj Gupta, V. Khare, B. Yadav, Hetalben Amin, Rakesh Rana, Arunabh Tripathi, S. Khanduri, B. Sharma, B. Chandrasekhararao, Narayanam Srikanth, K. Dhiman","doi":"10.4103/ayu.ayu_11_21","DOIUrl":"https://doi.org/10.4103/ayu.ayu_11_21","url":null,"abstract":"Background: Currently, there is no approved treatment for the management of coronavirus disease (COVID-19). Drug repurposing of existing medications could be a possible way to find out a novel therapeutic entity to combat the COVID-19. Aim: To determine the clinical efficacy and safety of an Ayurveda intervention (Guduchighana Vati) in asymptomatic and mild-to-moderate cases of COVID-19. Materials and methods: This was an open-label randomized controlled pilot study with a sample size of 30 participants (15 in each arm). The participants were asymptomatic or mild to moderate cases of COVID-19. Guduchighana Vati 500 mg twice daily for 10 days was administered in the study group and Hydroxychloroquine for 5 days in the control group. Paracetamol, Vitamin C, Multivitamin, and Zinc were also provided in the control group. The main outcome measures were to negative real-time reverse transcription–polymerase chain reaction (RT-PCR) assay for COVID-19, proportion of participants with negative RT-PCR for COVID-19 at 5th and 10th day, proportion of participants with clinical recovery, improvement in laboratory parameters, and incidence of adverse drug reaction/adverse event (ADR/AE). The results of RT-PCR and clinical recovery were compared between groups using Chi-square test. The data related to laboratory parameters were compared within group using paired sample t-test/Wilcoxon signed-rank test and between groups using independent sample t-test/Mann–Whitney test. Results: The proportion of participants with negative RT-PCR for COVID-19 in the Guduchighana Vati group (93.3%) was better as compared to the control group (66.6%) till 10th day of the study period. Though, the results are statistically not significant (P = 0.068). All the symptomatic patients in the Guduchighana Vati group clinically recovered whereas one patient remained symptomatic in the control group on the 5th day. No symptoms of COVID-19 were observed at 10th day in both the groups. No ADR/serious adverse event were observed during the study period in either of the groups. Conclusion: In this study on asymptomatic and mild to moderate cases of COVID-19, Guduchighana Vati showed numerically better proportion of participants with negative RT-PCR assay for COVID-19 and reduced time to clinical improvement which requires confirmation through studies with larger sample size. Although, the study outcomes are statistically not significant which may be due to small sample size.","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81701607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Comparative pharmaceutico-analytical study of Rasamanikya prepared by two different Shodhana media of Haratala (orpiment) 两种不同培养基制备罗沙曼加的比较药学分析研究
Ayu
Pub Date : 2020-07-01 DOI: 10.4103/ayu.AYU_261_19
Dipali Parekh, Sarika M. Makwana, P. Bedarkar, B. Patgiri
Introduction: Foremost, Rasamanikya is described in Rasendra Chintamani by Acharya Dhundhuknath. It is a formulation that is prepared from the arsenical drug, i.e., orpiment (Haratala). Haratala is classified under Uparasa Varga in Rasa classics and is also included under Schedule E1 in D and C act 1940. In classics, there are so many media mentioned for purification process (Shodhana) of orpiment. In the present study, Kushmanda Swarasa (juice of Benincasa hispida [Thunb.] Cogn) and Churnodaka (lime water) are adopted as the purification media for orpiment. Aim: The aim of this study was to standardize the pharmaceutical procedure of Rasamanikya and develop a comparative analytical profile of both the formulation, i.e., Rasamanikya prepared by Kushmanda Swarasa and Churnodaka Shodhita Haratala. Materials and methods: The study was carried out in two stages as follows: Shodhana of Haratala and preparation of Rasamanikya by Kupipakwa method. Both the samples of Rasamanikya were analyzed for organoleptic and physicochemical parameters. The samples of final products were also analyzed through sophisticated analytical parameters, i.e., X-ray diffraction (XRD), Inductively coupled plasma-atomic emission spectroscopy (ICP-AES), CHNS and O, Field emission gun-scanning electron microscopy (FEG-SEM), Fourier transform infrared spectroscopy (FTIR) and Thermo-gravimetric analysis (TGA). Results: Average 2 h duration was required for the preparation of Rasamanikya formulation from 600 g of purified orpiment. In XRD analysis, both samples have different diffraction patterns. In ICP-AES analysis, both samples have the same percentage of arsenic. More percentage loss was noted in the TGA of Rasamanikya prepared with Churnodaka Shodhita Haratala than that of Kushmanda Swarasa Shodhita Haratala. Conclusion: Rasamanikya prepared by two different media of Shodhita Haratala did not found to have a substantial difference in pharmaceutical procedure. However, there was a considerable difference in the analytical study. Kupipakwa procedure can be used for large-scale preparation.
引言:首先,Rasamanikya是由Acharya Dhundhuknath在Rasendra Chintamani中描述的。它是一种由含砷药物,即orpiment (Haratala)制备的制剂。Haratala在Rasa经典中被归类为Uparasa Varga,也被列入1940年D和C法案的附表E1。在经典中,有很多媒体提到了净化过程(Shodhana)的装饰。在本研究中,Kushmanda Swarasa (Benincasa hispida [Thunb]的汁液)。[cn] Cogn)和Churnodaka(石灰水)作为净化介质。目的:本研究的目的是规范沙散散的制药工艺,并对库什曼达·斯瓦拉萨和原塔拉斯达制备的沙散散进行比较分析。材料与方法:本研究分两阶段进行,分别为:原达拉散食法和Kupipakwa法制备罗刹散食法。对两种药材的感官和理化参数进行了分析。通过x射线衍射(XRD)、电感耦合等离子体-原子发射光谱(ICP-AES)、CHNS和O、场发射枪扫描电子显微镜(fg - sem)、傅里叶变换红外光谱(FTIR)和热重分析(TGA)等精密分析参数对最终产品样品进行了分析。结果:以纯化的黄芪600 g为原料,平均制备时间为2 h。在XRD分析中,两种样品具有不同的衍射模式。在ICP-AES分析中,两种样品的砷含量相同。用Churnodaka Shodhita Haratala制备的Rasamanikya的TGA损失百分比大于Kushmanda Swarasa Shodhita Haratala。结论:两种不同培养基制备的罗沙曼加在制药工艺上无明显差异。然而,在分析研究中存在相当大的差异。Kupipakwa法可用于大规模制备。
{"title":"Comparative pharmaceutico-analytical study of Rasamanikya prepared by two different Shodhana media of Haratala (orpiment)","authors":"Dipali Parekh, Sarika M. Makwana, P. Bedarkar, B. Patgiri","doi":"10.4103/ayu.AYU_261_19","DOIUrl":"https://doi.org/10.4103/ayu.AYU_261_19","url":null,"abstract":"Introduction: Foremost, Rasamanikya is described in Rasendra Chintamani by Acharya Dhundhuknath. It is a formulation that is prepared from the arsenical drug, i.e., orpiment (Haratala). Haratala is classified under Uparasa Varga in Rasa classics and is also included under Schedule E1 in D and C act 1940. In classics, there are so many media mentioned for purification process (Shodhana) of orpiment. In the present study, Kushmanda Swarasa (juice of Benincasa hispida [Thunb.] Cogn) and Churnodaka (lime water) are adopted as the purification media for orpiment. Aim: The aim of this study was to standardize the pharmaceutical procedure of Rasamanikya and develop a comparative analytical profile of both the formulation, i.e., Rasamanikya prepared by Kushmanda Swarasa and Churnodaka Shodhita Haratala. Materials and methods: The study was carried out in two stages as follows: Shodhana of Haratala and preparation of Rasamanikya by Kupipakwa method. Both the samples of Rasamanikya were analyzed for organoleptic and physicochemical parameters. The samples of final products were also analyzed through sophisticated analytical parameters, i.e., X-ray diffraction (XRD), Inductively coupled plasma-atomic emission spectroscopy (ICP-AES), CHNS and O, Field emission gun-scanning electron microscopy (FEG-SEM), Fourier transform infrared spectroscopy (FTIR) and Thermo-gravimetric analysis (TGA). Results: Average 2 h duration was required for the preparation of Rasamanikya formulation from 600 g of purified orpiment. In XRD analysis, both samples have different diffraction patterns. In ICP-AES analysis, both samples have the same percentage of arsenic. More percentage loss was noted in the TGA of Rasamanikya prepared with Churnodaka Shodhita Haratala than that of Kushmanda Swarasa Shodhita Haratala. Conclusion: Rasamanikya prepared by two different media of Shodhita Haratala did not found to have a substantial difference in pharmaceutical procedure. However, there was a considerable difference in the analytical study. Kupipakwa procedure can be used for large-scale preparation.","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82736945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Efficacy of Vyoshadi Guggulu and Shadushana Churna in the management of subclinical hypothyroidism: An open labelled randomized comparative pilot clinical trial Vyoshadi Guggulu和Shadushana Churna治疗亚临床甲状腺功能减退的疗效:一项开放标记随机对照临床试验
Ayu
Pub Date : 2020-07-01 DOI: 10.4103/ayu.ayu_359_20
V. B. Sharma, B. Padhar, H. Meena, S. Mathur
Background: Subclinical hypothyroidism (SCH) is defined as a mildly reduced function of the thyroid gland having elevated serum thyroid-stimulating hormone (TSH) level and normal concentrations of free tri-iodothyronine (FT3), free tetra-iodothyronine (FT4), T3 and T4. It occurs due to “Agnimandya” (low metabolic activity) at the systemic and cellular level. Vyoshadi Guggulu and Shadushana Churna having its effect on Agni (a root cause of SCH) are expected to prevent overt hypothyroidism and revert subclinical stage to euthyroid. Aim: This study was planned to evaluate and compare the efficacy of Vyoshadi Guggulu and Shadushana Churna in the management of Dhatvagnimandya with special reference to sub-clinical hypothyroidism (SCH). Materials and methods: Patients having serum TSH levels between 5 and 10 mlU/L and normal T3 and T4 values were diagnosed as SCH. A total of 30 patients were registered and randomly divided into two groups. In group A, patients were treated with Vyoshadi Guggulu (6 g), while in group B with Shadushana Churna (3 g) twice a day after lunch and dinner for 60 days. The assessment was done through changes in baseline and after treatment values of serum TSH level. Outcomes of the trial were analyzed using SigmaStat 4.0 version (trial) software. Student's paired t-test was used for within-group assessment, while unpaired t-test was used for intergroup comparison of the normally distributed parametric data. Observations and Results: Ten patients in group A and 11 in group B could complete the course of treatment. The findings revealed that therapy in group A and B showed decrease of 16.61% (P = 0.0494) and 26.29% (P = 0.0140) in serum TSH, respectively, 1.80% (P = 0.025) and 1.36% (P = 0.019) decrease in body mass index (BMI), respectively. The decrease in TSH and BMI was statistically significant in each group. In comparison, the decrease in serum TSH (P = 0.384) and BMI (P = 0.677) was statistically insignificant. Conclusions: Vyoshadi Guggulu and Shadushana Churna are statistically equally effective to reduce serum TSH and BMI in the management of SCH.
背景:亚临床甲状腺功能减退症(SCH)被定义为甲状腺功能轻度降低,血清促甲状腺激素(TSH)水平升高,游离三碘甲状腺原氨酸(FT3)、游离四碘甲状腺原氨酸(FT4)、T3和T4浓度正常。它的发生是由于“Agnimandya”(低代谢活动)在系统和细胞水平。Vyoshadi Guggulu和Shadushana Churna对Agni (SCH的根本原因)有作用,有望预防明显的甲状腺功能减退,并将亚临床阶段恢复到甲状腺功能正常。目的:评价和比较Vyoshadi Guggulu和Shadushana Churna治疗亚临床甲状腺功能减退症(SCH)的疗效。材料与方法:将血清TSH水平在5 ~ 10 mlU/L之间,T3、T4值正常的患者诊断为SCH。30例患者随机分为两组。A组患者服用Vyoshadi Guggulu (6 g), B组患者服用Shadushana Churna (3 g),每天两次,午餐和晚餐后服用,连续60天。通过基线和治疗后血清TSH水平的变化进行评估。使用SigmaStat 4.0版本(试用版)软件对试验结果进行分析。组内评价采用学生配对t检验,组间比较采用非配对t检验。观察与结果:A组10例,B组11例均能完成疗程。结果显示,A组和B组血清TSH分别下降16.61% (P = 0.0494)和26.29% (P = 0.0140),体重指数(BMI)分别下降1.80% (P = 0.025)和1.36% (P = 0.019)。各组TSH和BMI下降均有统计学意义。相比之下,血清TSH (P = 0.384)和BMI (P = 0.677)的下降无统计学意义。结论:Vyoshadi Guggulu和Shadushana Churna在降低血清TSH和BMI方面具有统计学上相同的疗效。
{"title":"Efficacy of Vyoshadi Guggulu and Shadushana Churna in the management of subclinical hypothyroidism: An open labelled randomized comparative pilot clinical trial","authors":"V. B. Sharma, B. Padhar, H. Meena, S. Mathur","doi":"10.4103/ayu.ayu_359_20","DOIUrl":"https://doi.org/10.4103/ayu.ayu_359_20","url":null,"abstract":"Background: Subclinical hypothyroidism (SCH) is defined as a mildly reduced function of the thyroid gland having elevated serum thyroid-stimulating hormone (TSH) level and normal concentrations of free tri-iodothyronine (FT3), free tetra-iodothyronine (FT4), T3 and T4. It occurs due to “Agnimandya” (low metabolic activity) at the systemic and cellular level. Vyoshadi Guggulu and Shadushana Churna having its effect on Agni (a root cause of SCH) are expected to prevent overt hypothyroidism and revert subclinical stage to euthyroid. Aim: This study was planned to evaluate and compare the efficacy of Vyoshadi Guggulu and Shadushana Churna in the management of Dhatvagnimandya with special reference to sub-clinical hypothyroidism (SCH). Materials and methods: Patients having serum TSH levels between 5 and 10 mlU/L and normal T3 and T4 values were diagnosed as SCH. A total of 30 patients were registered and randomly divided into two groups. In group A, patients were treated with Vyoshadi Guggulu (6 g), while in group B with Shadushana Churna (3 g) twice a day after lunch and dinner for 60 days. The assessment was done through changes in baseline and after treatment values of serum TSH level. Outcomes of the trial were analyzed using SigmaStat 4.0 version (trial) software. Student's paired t-test was used for within-group assessment, while unpaired t-test was used for intergroup comparison of the normally distributed parametric data. Observations and Results: Ten patients in group A and 11 in group B could complete the course of treatment. The findings revealed that therapy in group A and B showed decrease of 16.61% (P = 0.0494) and 26.29% (P = 0.0140) in serum TSH, respectively, 1.80% (P = 0.025) and 1.36% (P = 0.019) decrease in body mass index (BMI), respectively. The decrease in TSH and BMI was statistically significant in each group. In comparison, the decrease in serum TSH (P = 0.384) and BMI (P = 0.677) was statistically insignificant. Conclusions: Vyoshadi Guggulu and Shadushana Churna are statistically equally effective to reduce serum TSH and BMI in the management of SCH.","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90075544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Virechana, Triphaladi decoction with processed Guggulu in the management of ovarian cyst - A pilot study 牛头草汤联合谷谷露治疗卵巢囊肿的初步研究
Ayu
Pub Date : 2020-07-01 DOI: 10.4103/ayu.AYU_254_19
Matangee Pandya, S. Donga, L. Dei, A. Thakar
Background: Ovarian cyst is an emerging problem among the women of reproductive age group. Most of the ovarian cyst (80%–85%) are benign, and two-thirds of these occur in women between 20 and 44 years of age. They may be identified in asymptomatic women during routine pelvic examination or may produce symptoms. Management of the ovarian cyst through surgery is available to meet urgent need of the patient, but to establish a satisfactory conservatory medical treatment is the need of the hour. According to Ayurveda, ovarian cysts can be managed on the line of Kaphaja Granthi (nodular/glandular swellings by Kapha Dosha) and Vidradhi (abscess). Aim: The aim of this study was to evaluate the clinical efficacy of Virechana (therapeutic purgation), Triphaladi Kashaya (decoction) with processed Guggulu (Commiphora mukul Engl.) in the management of ovarian cyst. Materials and methods: 16 patients were included in this clinical study and among them, 15 patients completed the treatment and one patient was dropped out from the trial. Patients were given Virechana followed by Triphaladi Kashaya (50 ml) with processed Guggulu (1 g) orally twice a day before meal for 60 days. The patients were followed up till 1 month. The assessment was carried out on subjective parameters such as lower abdominal pain, backache, and dysmenorrhea as well as objective parameters such as ovarian cyst size and volume by four-dimensional gray scale and color doppler sonography. Cancer antigen 125 was also assessed before and after treatment. Results were statistically analyzed using Wilcoxon signed-rank test and Student's t-test by sigma statistical tool (version 3.5, Systat Software Inc., United States). Results: Significant results were observed in subjective parameters such as lower abdominal pain (93.11%), backache (81.81) and dysmenorrhea (90.90%) as well as objective parameters such as reduction in size of the cyst (60%) and complete resolution of the cyst (26.66%). Conclusion: Triphaladi Kashaya with processed Guggulu is more effective in hemorrhagic cyst and simple cyst rather than other cyst, due to Shothahara properties which may have effectively curtailed the progress of ovarian cyst.
背景:卵巢囊肿是育龄妇女的一个新兴问题。大多数卵巢囊肿(80%-85%)是良性的,其中三分之二发生在20至44岁的女性中。它们可能在无症状的妇女在常规盆腔检查中被发现或可能产生症状。通过手术治疗卵巢囊肿可以满足患者的迫切需要,但建立一个令人满意的医学治疗环境是当务之急。根据阿育吠陀的说法,卵巢囊肿可以通过Kaphaja Granthi (Kapha Dosha的结节/腺体肿胀)和Vidradhi(脓肿)来治疗。目的:本研究的目的是评价维雷查那(治疗性泻药)、三七汤(煎剂)与古古露(古古露)联合治疗卵巢囊肿的临床疗效。材料与方法:本临床研究共纳入16例患者,其中15例患者完成治疗,1例患者退出试验。患者服用Virechana,随后服用Triphaladi Kashaya (50 ml)和加工过的Guggulu (1 g),每天两次,餐前口服,连续60天。随访1个月。采用四维灰度和彩色多普勒超声对下腹痛、背痛、痛经等主观参数和卵巢囊肿大小、体积等客观参数进行评价。癌症抗原125也在治疗前后进行了评估。统计分析采用Wilcoxon sign -rank检验和Student’st检验,采用sigma统计工具(3.5版,Systat Software Inc.,美国)。结果:下腹痛(93.11%)、背痛(81.81)、痛经(90.90%)等主观指标及囊肿缩小(60%)、囊肿完全溶解(26.66%)等客观指标均取得显著效果。结论:复方谷谷露对出血性囊肿和单纯性囊肿的治疗效果优于其他类型的囊肿,因为复方谷谷露具有Shothahara的特性,可能有效地延缓了卵巢囊肿的发展。
{"title":"Efficacy of Virechana, Triphaladi decoction with processed Guggulu in the management of ovarian cyst - A pilot study","authors":"Matangee Pandya, S. Donga, L. Dei, A. Thakar","doi":"10.4103/ayu.AYU_254_19","DOIUrl":"https://doi.org/10.4103/ayu.AYU_254_19","url":null,"abstract":"Background: Ovarian cyst is an emerging problem among the women of reproductive age group. Most of the ovarian cyst (80%–85%) are benign, and two-thirds of these occur in women between 20 and 44 years of age. They may be identified in asymptomatic women during routine pelvic examination or may produce symptoms. Management of the ovarian cyst through surgery is available to meet urgent need of the patient, but to establish a satisfactory conservatory medical treatment is the need of the hour. According to Ayurveda, ovarian cysts can be managed on the line of Kaphaja Granthi (nodular/glandular swellings by Kapha Dosha) and Vidradhi (abscess). Aim: The aim of this study was to evaluate the clinical efficacy of Virechana (therapeutic purgation), Triphaladi Kashaya (decoction) with processed Guggulu (Commiphora mukul Engl.) in the management of ovarian cyst. Materials and methods: 16 patients were included in this clinical study and among them, 15 patients completed the treatment and one patient was dropped out from the trial. Patients were given Virechana followed by Triphaladi Kashaya (50 ml) with processed Guggulu (1 g) orally twice a day before meal for 60 days. The patients were followed up till 1 month. The assessment was carried out on subjective parameters such as lower abdominal pain, backache, and dysmenorrhea as well as objective parameters such as ovarian cyst size and volume by four-dimensional gray scale and color doppler sonography. Cancer antigen 125 was also assessed before and after treatment. Results were statistically analyzed using Wilcoxon signed-rank test and Student's t-test by sigma statistical tool (version 3.5, Systat Software Inc., United States). Results: Significant results were observed in subjective parameters such as lower abdominal pain (93.11%), backache (81.81) and dysmenorrhea (90.90%) as well as objective parameters such as reduction in size of the cyst (60%) and complete resolution of the cyst (26.66%). Conclusion: Triphaladi Kashaya with processed Guggulu is more effective in hemorrhagic cyst and simple cyst rather than other cyst, due to Shothahara properties which may have effectively curtailed the progress of ovarian cyst.","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90350318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Laksha Churna and Madhu Pratisarana after ultrasonic scaling in the management of Dantasharkara (dental calculus): An open-label, standard controlled randomized clinical trial 超声刮治后Laksha Churna和Madhu Pratisarana在牙石治疗中的作用:一项开放标签、标准对照、随机临床试验
Ayu
Pub Date : 2020-07-01 DOI: 10.4103/ayu.AYU_274_20
Divyarani Kathad, Hemangi Shukla, M. Goyal
Background: Dental calculus is one of the major problems in dentistry, which is characterized by calcified mass that forms on and adheres to the surface of teeth resulting in bad breath, receding gums and chronically inflamed gingiva. It can be correlated with Dantasharkara (dental calculus), which is characterized by the collection of hardened accumulation of Mala (tartar) at the junction of teeth and gums. Ultrasonic scalars are used for the removal of dental calculus for convenience. In texts, Laksha Churna (powder of Laccifer lacca Kerr) has been mentioned as Vranaropaka (wound healing) and indicated for the eliminating plaque through cleaning and polishing tooth surfaces. Aim: This study was aimed to evaluate the clinical efficacy of local application of Laksha Churna and Madhu (honey) Pratisarana after Dantasharkara Nirharana (scaling of dental calculus) in the management of Dantasharkara (dental calculus). Materials and methods: Patients having calculus deposition, fulfilling the inclusion criteria were selected. In group A, Pratisarana with Laksha Churna (powder) 1 g and Madhu as per requirement was given, whereas in group B, chlor-hexidine gluconate 0.2% for gargling was given for 2 weeks. Ultrasonic scaling was done in both groups before given trial drugs. The outcomes were calculated on the base on changes in score of the subjective parameters like pain, inflammation of gum, bleeding gums, halitosis as well as objective parameters like oral hygiene index, debris index, calculus index, gingival index, and periodontal index. For analysing the effect of the result, Wilcoxon signed-rank test for nonparametric paired data and paired t-test for quantitative parametric paired data was applied. Results: After analysing the data, it was found that Ultrasonic scaling of dental calculus followed by Pratisaraņa of honey with Laksha Churna provided statistically significant improvement in calculus index (97.77%) in debris index (84.44%), in oral hygiene index(96.66%), in gingival index (83.33%)and showed 96.15% improvement in periodontal index, whereas Ultrasonic scaling of dental calculus followed by gargling with chlorhexidine gluconate 0.2% provided 80% improvement in calculus index, 70% in debris index, 90% in oral hygiene index, in gingival index by 73.06%, and 93.75% improvement periodontal index which was statistically significant. Conclusion: The present study indicates Dantasharkara Nirharana followed by Pratisarana of Laksha Churna and Madhu is comparatively more effective than conventional standard treatment protocol (ultrasonic scaling and chlorhexidine gluconate mouth wash) in the management of dental calculus.
背景:牙结石是牙科的主要问题之一,其特征是在牙齿表面形成并粘附在牙齿表面的钙化团块,导致口臭,牙龈萎缩和牙龈慢性炎症。它可能与Dantasharkara(牙结石)有关,其特征是牙齿和牙龈交界处Mala(牙垢)的硬化堆积。为方便起见,使用超声标量器去除牙结石。在文本中,Laksha Churna (Laccifer lacca Kerr的粉末)被提到为Vranaropaka(伤口愈合),并指出通过清洁和抛光牙齿表面来消除菌斑。目的:本研究旨在评价牙石刮除术后局部应用Laksha Churna和Madhu (honey) Pratisarana治疗牙石刮除术的临床疗效。材料和方法:选择符合纳入标准的结石沉积患者。A组患者按要求给予藿香粉(散)1 g和马杜,B组患者给予葡萄糖酸氯己定0.2%漱口,疗程2周。两组患者在给药前均行超声洗牙。根据疼痛、牙龈炎症、牙龈出血、口臭等主观参数和口腔卫生指数、牙垢指数、牙石指数、牙龈指数、牙周指数等客观参数的评分变化来计算结果。为分析结果的影响,对非参数配对数据采用Wilcoxon符号秩检验,对定量参数配对数据采用配对t检验。结果:经数据分析发现,超声洁牙后用拉克沙蜂蜜Pratisaraņa洁牙后,牙石指数(97.77%)、牙屑指数(84.44%)、口腔卫生指数(96.66%)、牙龈指数(83.33%)改善,牙周指数改善96.15%,而超声洁牙后用葡萄糖酸氯己定0.2%漱口,牙石指数改善80%。杂物指数改善70%,口腔卫生指数改善90%,牙龈指数改善73.06%,牙周指数改善93.75%,差异有统计学意义。结论:本研究表明,丹参散膏联合拉克沙丘尔纳和马杜散膏治疗牙石的效果优于常规标准治疗方案(超声洗牙和葡萄糖酸氯己定漱口水)。
{"title":"Role of Laksha Churna and Madhu Pratisarana after ultrasonic scaling in the management of Dantasharkara (dental calculus): An open-label, standard controlled randomized clinical trial","authors":"Divyarani Kathad, Hemangi Shukla, M. Goyal","doi":"10.4103/ayu.AYU_274_20","DOIUrl":"https://doi.org/10.4103/ayu.AYU_274_20","url":null,"abstract":"Background: Dental calculus is one of the major problems in dentistry, which is characterized by calcified mass that forms on and adheres to the surface of teeth resulting in bad breath, receding gums and chronically inflamed gingiva. It can be correlated with Dantasharkara (dental calculus), which is characterized by the collection of hardened accumulation of Mala (tartar) at the junction of teeth and gums. Ultrasonic scalars are used for the removal of dental calculus for convenience. In texts, Laksha Churna (powder of Laccifer lacca Kerr) has been mentioned as Vranaropaka (wound healing) and indicated for the eliminating plaque through cleaning and polishing tooth surfaces. Aim: This study was aimed to evaluate the clinical efficacy of local application of Laksha Churna and Madhu (honey) Pratisarana after Dantasharkara Nirharana (scaling of dental calculus) in the management of Dantasharkara (dental calculus). Materials and methods: Patients having calculus deposition, fulfilling the inclusion criteria were selected. In group A, Pratisarana with Laksha Churna (powder) 1 g and Madhu as per requirement was given, whereas in group B, chlor-hexidine gluconate 0.2% for gargling was given for 2 weeks. Ultrasonic scaling was done in both groups before given trial drugs. The outcomes were calculated on the base on changes in score of the subjective parameters like pain, inflammation of gum, bleeding gums, halitosis as well as objective parameters like oral hygiene index, debris index, calculus index, gingival index, and periodontal index. For analysing the effect of the result, Wilcoxon signed-rank test for nonparametric paired data and paired t-test for quantitative parametric paired data was applied. Results: After analysing the data, it was found that Ultrasonic scaling of dental calculus followed by Pratisaraņa of honey with Laksha Churna provided statistically significant improvement in calculus index (97.77%) in debris index (84.44%), in oral hygiene index(96.66%), in gingival index (83.33%)and showed 96.15% improvement in periodontal index, whereas Ultrasonic scaling of dental calculus followed by gargling with chlorhexidine gluconate 0.2% provided 80% improvement in calculus index, 70% in debris index, 90% in oral hygiene index, in gingival index by 73.06%, and 93.75% improvement periodontal index which was statistically significant. Conclusion: The present study indicates Dantasharkara Nirharana followed by Pratisarana of Laksha Churna and Madhu is comparatively more effective than conventional standard treatment protocol (ultrasonic scaling and chlorhexidine gluconate mouth wash) in the management of dental calculus.","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77193831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Ayu
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1